Does PENTOSTATIN Cause Product use in unapproved indication? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Product use in unapproved indication have been filed in association with PENTOSTATIN (Nipent). This represents 5.1% of all adverse event reports for PENTOSTATIN.
23
Reports of Product use in unapproved indication with PENTOSTATIN
5.1%
of all PENTOSTATIN reports
4
Deaths
0
Hospitalizations
How Dangerous Is Product use in unapproved indication From PENTOSTATIN?
Of the 23 reports, 4 (17.4%) resulted in death, and 2 (8.7%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PENTOSTATIN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does PENTOSTATIN Cause?
Neutropenia (42)
Drug ineffective (37)
Off label use (32)
Bk virus infection (30)
Anaemia (28)
Dyspnoea (24)
Pyrexia (24)
Thrombocytopenia (24)
Cystitis haemorrhagic (23)
Sepsis (23)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which PENTOSTATIN Alternatives Have Lower Product use in unapproved indication Risk?
PENTOSTATIN vs PENTOXIFYLLINE
PENTOSTATIN vs PERAMIVIR
PENTOSTATIN vs PERAMPANEL
PENTOSTATIN vs PERAZINE
PENTOSTATIN vs PERCOCET